
To provide rationale for using zzso zzso zzso and/or zzso protein zzso zzso zzso zzso to treat zzso a major cause of pediatric and adolescent cancer zzso 

The prevalence of zzso zzso zzso in zzso clinical samples was assessed using zzso zzso signaling and zzso between zzso pathways was determined in zzso cell lines following zzso short hairpin zzso zzso zzso zzso of zzso signaling in stable zzso zzso lines was used to determine the zzso profile inducing zzso growth zzso The in zzso and in zzso efficacy of zzso of zzso zzso zzso zzso and zzso zzso was evaluated alone and in zzso zzso 

zzso zzso zzso was seen in zzso zzso with zzso zzso in zzso and zzso of zzso and zzso zzso zzso zzso zzso in cell lines over the short and long term was associated with zzso expression of other zzso zzso zzso of the zzso pathway, and zzso to reactivate the zzso zzso zzso of zzso zzso and zzso zzso zzso zzso zzso inhibited cell growth in zzso Treatment of zzso cells with zzso plus zzso blocked zzso zzso zzso as evidenced by reduced zzso zzso In zzso the synergistic effect on growth and changes in zzso zzso was zzso using the zzso combination but not zzso zzso analysis provided evidence of zzso interaction with both zzso 

zzso zzso zzso zzso and zzso signaling in both zzso zzso predict a lack of clinical efficacy for single agents targeting either pathway, supporting a therapeutic strategy combining a zzso with a zzso zzso 

